Guangzhou Mei Dan Titanium Dioxide Co., Ltd. – Trademark Portfolio

Entity Type: 99

Guangzhou Mei Dan Titanium Dioxide Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 2 (Paints) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include MEIDAN. The owner is based in Guangzhou.

705, C3, PanShan Advanced Business Park

No.537 North of panyu Avenue

Guangzhou 511400 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

MEIDAN
MEIDAN
Registered 2020

Trademark Classifications

Guangzhou Mei Dan Titanium Dioxide Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

2
Paints (1 filing)

Paints, varnishes, lacquers; preservatives against rust and against deterioration of wood

Frequently Asked Questions

How many trademarks does Guangzhou Mei Dan Titanium Dioxide Co., Ltd. have?

Guangzhou Mei Dan Titanium Dioxide Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Guangzhou Mei Dan Titanium Dioxide Co., Ltd. file in?

Guangzhou Mei Dan Titanium Dioxide Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 2 (Paints). Class 2 covers paints, varnishes, lacquers; preservatives against rust and against deterioration of wood.

What are Guangzhou Mei Dan Titanium Dioxide Co., Ltd.'s most well-known trademarks?

Guangzhou Mei Dan Titanium Dioxide Co., Ltd.'s registered trademark portfolio includes well-known marks such as MEIDAN. These are among 1 currently registered trademark in the portfolio.

What is Guangzhou Mei Dan Titanium Dioxide Co., Ltd.'s trademark registration success rate?

Guangzhou Mei Dan Titanium Dioxide Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.